Table I.
Detecting sera
|
|||||||
---|---|---|---|---|---|---|---|
Sample | Pathology | Extraction | Sarcoidosis | Control | Antigenic bands (kD) |
Anti-mKatG (IT57) |
|
Sarcoidosis | |||||||
S1 | LNa | NCGb | TX100 | −c | − | none | − |
S2 | LN | NCG | TX100 | + | − | 60 | + |
S3 | LN | NCG | TX100 | + | ND | 62, 64 | − |
S4 | LN | NCG | TX100 | − | ND | none | ND |
S5 | LN | NCG | TX100 | + | − | 62, 64 | + |
S6 | LN | NCG | TX100 | + | ND | 62, 64, 80 | − |
S7 | LN | NCG | TX100 | + | ND | ∼160 | ND |
S8 | LN | NCG | TX100 | + | − | 62 | ND |
S9 | LN | no grand | TX100 | − | − | none | − |
S10 | SPLe | NCG | TX100 | + | − | 60, 62 | + |
S11 | SPL | NCG | TX100 | + | + | 60, 62f, 64f, 150, 160 | |
Sarkosyl | + | + | 60, 62f, 64f, 150, 160 | + | |||
S12 | LUg | NCG | TX100 | + | ND | ∼160 | |
Sarkosyl | + | − | 60, 62, ∼160 | + | |||
Controls | |||||||
C1 | LN | no pathh | TX100 | − | − | none | ND |
C2 | LN | no path | TX100 | + | − | 62 | − |
C3 | LN | no path | TX100 | − | − | none | − |
C4 | LN | no path | TX100 | − | − | none | − |
C5 | LN | no path | TX100 | − | − | none | − |
C6 | LN | FHi | TX100 | − | − | none | − |
C7 | LN | FH | TX100 | − | ND | none | ND |
C8 | LN | no path | TX100 | − | ND | none | − |
C9 | LN | no path | TX100 | − | ND | none | − |
C10 | LN | no path | TX100 | − | − | none | − |
C11 | LN | no path | TX100 | − | ND | none | ND |
C12 | SPL | no path | TX100 | − | ND | none | − |
C13 | SPL | no path | TX100 | − | − | none | − |
C14 | SPL | no path | Sarkosyl | − | ND | none | ND |
C15 | SPL | no path | Sarkosyl | − | − | none | ND |
C16 | SPL | no path | Sarkosyl | − | − | none | ND |
C17 | SPL | no path | Sarkosyl | − | ND | none | − |
C18 | SPL | no path | TX100 | − | − | none | − |
C19 | SPL | no path | TX100 | − | ND | none | |
Sarkosyl | + | + | 62f, 64f | − | |||
C20 | SPL | no path | Sarkosyl | − | − | none | ND |
C21 | SPL | no path | TX100 | + | ND | 62, 64 | ND |
C22 | LU | no path | TX100 | − | ND | none | − |
Sarkosyl | − | ND | none | − |
Lymph node.
Noncaseating granuloma.
−, no clearly detectable band; +, presence of bands not seen with secondary antibody alone.
No granuloma.
Spleen.
Bands also seen with control sera.
Lung.
No tumor, granuloma, or other identified pathology.
Follicular hyperplasia.